| Net income | |
| Depreciation and amortization | |
| Amortization of debt issuance costs | |
| Amortization of debt discount | |
| Deferred income taxes | -21.84M |
| Stock-based compensation expense | |
| Gain on sale of property, buildings and equipment | |
| Asset impairment charge | |
| Equity income, net of distributions of $1,864 | |
| Excess tax benefit from stock-based compensation | |
| Interest related to uncertain tax positions | |
| Trade and other receivables, net | -15.52M |
| Inventories, net | -7.65M |
| Prepaid expenses and other current assets | -8.63M |
| Accounts payable | -30.29M |
| Accrued payroll and benefit costs | -2.65M |
| Other current and noncurrent liabilities | 37M |
| Net cash provided by operating activities | 217.19M |
| Capital expenditures | -13.18M |
| Acquisition payments | |
| Proceeds from sale of subsidiary | |
| Equity distribution | |
| Collection of note receivable | |
| Proceeds from sale of assets | |
| Net cash (used) provided by investing activities | -67.81M |
| Proceeds from issuance of long-term debt | 1.73B |
| Repayments of long-term debt | -1.92B |
| Debt issuance costs | |
| Proceeds from the exercise of stock options | |
| Excess tax benefit from stock-based compensation | |
| Purchases of common stock | -4.07M |
| Increase (decrease) in bank overdrafts | |
| Payments on capital lease obligations | |
| Net cash (used) provided by financing activities | -198.09M |
| Effect of exchange rate changes on cash and cash equivalents | 1.27M |
| Net change in cash and cash equivalents | -47.44M |
| Cash and cash equivalents at the beginning of period | 160.28M |
| Cash and cash equivalents at the end of period | 112.84M |
| Property, buildings and equipment acquired through capital leases | |
| Issuance of treasury stock | |